Comparison of three commercial ultrasonic nebulizers

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 2, 2000, Pages 255-261

  Katial, Rohit K ^a   Reisner, Colin ^b   Buchmeier, Andrea ^b   Bartelson, Becki Bucher ^b   Nelson, Harold S ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ARTICLE; COMPARATIVE STUDY; DEVICE; DRUG DELIVERY SYSTEM; NEBULIZER; PRIORITY JOURNAL;

EID: 0034009527     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62763-9     Document Type: Article

References (18)

1. Dennis JH, Hendrick DJ. Design characteristics for drug nebulizers. J Med Eng Technol 1992;16(2):63-68.
2. Newman S,G.D.P., Clarke SW. In-vitro comparison of DeVilbiss jet and Ultrasonic nebulizers. Chest 1987; 92(6):991-994.
3. Mercer TT. Production and characterization of aerosols. Arch Intern Med 1973;131:39-50.
4. Mercer TT. Production of therapeutic aerosols; principles and techniques. Chest 1981;80(Suppl):818-820.
5. Newman SP. Therapeutic aerosols. In: Clarke S, Demetri P, eds. Aerosols and the lung: clinical and experimental aspects. Butterworths: New York 1984: 206.
6. Toothaker LE. Multiple comparisons for researchers. Sage Publications: California, 1991:98-105.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310.
8. Sterk PJ, PlompA, Vander de Vate JF, Quayer PH. Physical properties of aerosols produced by several jet and ultrasonic nebulizers. Bull Eur Physiopathol Respir 1984;20:65-72.
9. Mercer TT, Goddard RF, Flores RL. Output characteristics of three ultrasonic nebulizers. Ann Allergy 1968; 26:18-27.
10. Moren F. Aerosol dosage forms and formulations. In: Moren F, Dolovich MB, Newhouse MT, Newman SP, eds. Aerosols in medicine, principles, diagnosis and therapy. Elsevier: New York 1993:322.
11. Newman SP, Clarke SW. Therapeutic aerosols: 1. Physical and practical aspects. Thorax 1983;38:881-886.
12. Newman SP. Therapeutic aerosol deposition in man. In: Moren F, Dolovich MB, Newhouse MT, Newman SP, eds. Aerosols in medicine, principles, diagnosis and therapy. Elsevier: New York 1993:375.
13. Newman SP. Therapeutic aerosols. In: Clarke S, Demetri P, eds. Aerosols and the lung: clinical and experimental aspects. Butterworths: New York 1984: 203-204.
14. Zanen P, Go L, Lammers JW. Optimal particle size for β2 agonist and anticholinergic aerosols in patients with severe airflow obstruction. Thorax 1996;51: 977-980.
15. Gonda I. Therapeutic aerosols. In: Aulton M, ed. Pharmaceutics: the science of dosage form design. Churchill Livingstone: New York 1988: 341-358.
16. Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994;106:1788-1793.
17. Malone RA, Hollie MC, Barnhart AG, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest 1993; 104:1114-1118.
18. Hess D, et al. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996;110:498-505.